Whitehawk Therapeutics, Inc.
WHWK
$1.93
$0.063.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.15M | 7.24M | 7.21M | 6.18M | 5.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.15M | 7.24M | 7.21M | 6.18M | 5.35M |
| Cost of Revenue | 9.55M | 15.14M | 10.80M | 13.87M | 14.25M |
| Gross Profit | -2.40M | -7.90M | -3.59M | -7.69M | -8.89M |
| SG&A Expenses | 12.82M | 11.05M | 7.19M | 7.89M | 10.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.36M | 26.19M | 17.99M | 21.76M | 24.87M |
| Operating Income | -15.22M | -18.95M | -10.78M | -15.58M | -19.51M |
| Income Before Tax | 73.02M | -18.27M | -12.55M | -14.58M | -18.29M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 73.02M | -18.27M | -12.55M | -14.58M | -18.29M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 73.02M | -18.27M | -12.55M | -14.58M | -18.29M |
| EBIT | -15.22M | -18.95M | -10.78M | -15.58M | -19.51M |
| EBITDA | -15.16M | -18.90M | -10.73M | -15.54M | -19.46M |
| EPS Basic | 1.84 | -0.67 | -0.46 | -0.54 | -0.68 |
| Normalized Basic EPS | -0.23 | -0.42 | -0.23 | -0.34 | -0.42 |
| EPS Diluted | 1.83 | -0.67 | -0.46 | -0.54 | -0.68 |
| Normalized Diluted EPS | -0.23 | -0.42 | -0.23 | -0.34 | -0.42 |
| Average Basic Shares Outstanding | 39.64M | 27.09M | 27.04M | 27.01M | 26.98M |
| Average Diluted Shares Outstanding | 39.93M | 27.09M | 27.04M | 27.01M | 26.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |